MUSTANG BIO INC's ticker is MBIO and the CUSIP is 62818Q104. A total of 99 filers reported holding MUSTANG BIO INC in Q4 2020. The put-call ratio across all filers is 0.92 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $114 | -10.2% | 316,402 | -2.8% | 0.00% | -100.0% |
| Q4 2022 | $127 | -99.9% | 325,384 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $151,000 | +67.8% | 325,384 | +111.3% | 0.00% | – |
| Q2 2022 | $90,000 | +309.1% | 154,008 | +1021.0% | 0.00% | – |
| Q4 2021 | $22,000 | -98.5% | 13,738 | -96.8% | 0.00% | -100.0% |
| Q1 2021 | $1,423,000 | +6.8% | 428,745 | +21.9% | 0.01% | +20.0% |
| Q4 2020 | $1,332,000 | +872.3% | 351,843 | +718.1% | 0.01% | +400.0% |
| Q2 2020 | $137,000 | -61.4% | 43,006 | -67.6% | 0.00% | -50.0% |
| Q1 2020 | $355,000 | +53.7% | 132,850 | +134.7% | 0.00% | +100.0% |
| Q4 2019 | $231,000 | -4.9% | 56,601 | -24.4% | 0.00% | 0.0% |
| Q3 2019 | $243,000 | -33.2% | 74,831 | -24.2% | 0.00% | -50.0% |
| Q2 2019 | $364,000 | – | 98,752 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 297,500 | $300,000 | 0.47% |
| GSA CAPITAL PARTNERS LLP | 1,216,445 | $1,229,000 | 0.16% |
| Ikarian Capital, LLC | 546,824 | $551,000 | 0.07% |
| Sassicaia Capital Advisers LLC | 12,000 | $12,000 | 0.06% |
| EMFO, LLC | 32,000 | $32,000 | 0.03% |
| B. Riley Wealth Advisors, Inc. | 310,926 | $315,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 312,800 | $316,000 | 0.01% |
| Renaissance Technologies | 2,449,100 | $2,474,000 | 0.00% |
| Arete Wealth Advisors, LLC | 15,538 | $16,000 | 0.00% |
| Herold Advisors, Inc. | 4,000 | $4,040,000 | 0.00% |